Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
- 1 August 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354 (9180) , 701-707
- https://doi.org/10.1016/s0140-6736(99)07350-x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Management Strategies for a Better Outcome in Unstable Coronary Artery DiseaseClinical Cardiology, 1998
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery DiseaseCirculation, 1997
- Troponin T Identifies Patients With Unstable Coronary Artery Disease Who Benefit From Long-Term Antithrombotic ProtectionJournal of the American College of Cardiology, 1997
- A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Risk stratification by early exercise testing after an episode of unstable coronary artery diseaseInternational Journal of Cardiology, 1993
- Reactivation of Unstable Angina after the Discontinuation of HeparinNew England Journal of Medicine, 1992
- Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patientsEuropean Heart Journal, 1991